[236] reported that METTL3‐dependent m6A methylation increased miR‐181d‐5p expression, then inhibited the 5‐Fluorouracil sensitivity of CRC cells by targeting neurocalcin δ (Fig. 6G). The gene discussed is METTL3; the disease is colorectal carcinoma.